LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation
Cellular Oncology · 2024-10 · 47 (5) · 1679-1696
DOI: 10.1007/s13402-024-00947-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, online erschienen am 24.04.2024. Verfasst von Zhiyuan Jiang und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Oncology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Mice, Inbred BALB C, Tumor Escape, Mice, Nude. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Oncology, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University School of Medicine, 600 Yishan Road, Shanghai, China.
- Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, 280 South Chongqing Road, Huangpu District, 200025, Shanghai, China.
- Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Breast Surgery, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China.
- Department of Rheumatism and Immunology, Peking University Shenzhen Hospital, Shenzhen, Guangdong, China.
- Center for Cancer Immunology Research, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong, China.
Förderung
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Jiang, Z., Huang, Q., Chang, Y., Qiu, Y., Cheng, H., Yang, M., Ruan, S., Ji, S., Sun, J., Wang, Z., Xu, S., Liang, R., Dai, X., Wu, K., Li, B., Li, D., & Zhao, H. (2024). LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation. Cellular Oncology, 47(5), 1679-1696. https://doi.org/10.1007/s13402-024-00947-5
Vancouver
Jiang Z, Huang Q, Chang Y, Qiu Y, Cheng H, Yang M, et al. LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation. Cellular Oncology. 2024;47(5):1679-1696. doi:10.1007/s13402-024-00947-5
BibTeX
@article{Jiang2024,
author = {Jiang, Zhiyuan and Huang, Qianru and Chang, Yujie and Qiu, Yiran and Cheng, Hao and Yang, Mengdi and Ruan, Shunyi and Ji, Suyuan and Sun, Jing and Wang, Zhiyu and Xu, Shengyuan and Liang, Rui and Dai, Xueyu and Wu, Kejin and Li, Bin and Li, Dan and Zhao, Hui},
title = {LILRB2 promotes immune escape in breast cancer cells via enhanced HLA-A degradation},
journal = {Cellular Oncology},
year = {2024},
volume = {47},
number = {5},
pages = {1679--1696},
doi = {10.1007/s13402-024-00947-5}
}
EUVIMED